Research Papers

25 of 177 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Benzene Amide Ether Scaffold is Active against Non-replicating and Intracellular <i>Mycobacterium tuberculosis</i>.
Ahmed S; Chowdhury S; Gomez J; Hung DT; Parish T.
ACS Infect Dis (Unknown)
Published: 2023
4/6 Transparent
Code Funding Declared
Quantitative Imaging of the Action of vCPP2319, an Antimicrobial Peptide from a Viral Scaffold, against <i>Staphylococc…
Dias SA; Pinto SN; Silva-Herdade AS; Cavaco M; Neves V; Tavares L; Oliveira M; Andreu D; Coutinho A; Castanho MARB; Veiga AS.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A Pyridyl-Furan Series Developed from the Open Global Health Library Block Red Blood Cell Invasion and Protein Traffick…
Ling DB; Nguyen W; Looker O; Razook Z; McCann K; Barry AE; Scheurer C; Wittlin S; Famodimu MT; Delves MJ; Bullen HE; Crabb BS; Sleebs BE; Gilson PR.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Potent Antifungal Activity of Penta-<i>O</i>-galloyl-β-d-Glucose against Drug-Resistant <i>Candida albicans</i>, <i>Can…
Marquez L; Lee Y; Duncan D; Whitesell L; Cowen LE; Quave C.
ACS Infect Dis (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Galidesivir Triphosphate Promotes Stalling of Dengue-2 Virus Polymerase Immediately Prior to Incorporation.
Deshpande S; Huo W; Shrestha R; Sparrow K; Wood JM; Evans GB; Harris LD; Kingston RL; Bulloch EMM.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Nanoscaled Discovery of a Shunt Rifamycin from <i>Salinispora arenicola</i> Using a Three-Color GFP-Tagged <i>Staphyloc…
Pham NT; Alves J; Sargison FA; Cullum R; Wildenhain J; Fenical W; Butler MS; Mead DA; Duggan BM; Fitzgerald JR; La Clair JJ; Auer M.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Structure-Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis.
Dichiara M; Simpson QJ; Quotadamo A; Jalani HB; Huang AX; Millard CC; Klug DM; Tse EG; Todd MH; Silva DG; da Silva Emery F; Carlson JE; Zheng SL; Vleminckx M; Matheeussen A; Caljon G; Pollastri MP; Sjö P; Perry B; Ferrins L.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.
Mayorga-Ramos A; Zúñiga-Miranda J; Carrera-Pacheco SE; Barba-Ostria C; Guamán LP.
ACS Infect Dis (Unknown)
Published: 2023
2/6 Transparent
<i>Plasmodium falciparum</i> Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstr…
Dobrescu I; Hammam E; Dziekan JM; Claës A; Halby L; Preiser P; Bozdech Z; Arimondo PB; Scherf A; Nardella F.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Screen for New Antimicrobial Natural Products from the NCI Program for Natural Product Discovery Prefractionated Extrac…
Martínez-Fructuoso L; Arends SJR; Freire VF; Evans JR; DeVries S; Peyser BD; Akee RK; Thornburg CC; Kumar R; Ensel S; Morgan GM; McConachie GD; Veeder N; Duncan LR; Grkovic T; O'Keefe BR.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A Synthetic Cyclized Antimicrobial Peptide with Potent Effects against Drug-Resistant Skin Pathogens.
White JK; Mohanty S; Muhammad T; de Arriba Sanchez de la Campa M; Houssen WE; Ferraz N; Göransson U; Brauner A.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenav…
Stewart CM; Bo Y; Fu K; Chan M; Kozak R; Apperley KY; Laroche G; Daniel R; Beauchemin AM; Kobinger G; Kobasa D; Côté M.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Optimization of Host Cell-Compatible, Antimicrobial Peptides Effective against Biofilms and Clinical Isolates of Drug-R…
Ghimire J; Hart RJ; Soldano A; Chen CH; Guha S; Hoffmann JP; Hall KM; Sun L; Nelson BJ; Lu TK; Kolls JK; Rivera M; Morici LA; Wimley WC.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Urinary Glycosaminoglycans Are Associated with Recurrent UTI and Urobiome Ecology in Postmenopausal Women.
Neugent ML; Hulyalkar NV; Kumar A; Xing C; Zimmern PE; Shulaev V; De Nisco NJ.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndro…
Cha HM; Kim UI; Ahn SB; Lee MK; Lee H; Bang H; Jang Y; Kim SS; Bae MA; Kim K; Kim M.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Molecular Signatures of the Eagle Effect Induced by the Artificial Siderophore Conjugate LP-600 in <i>E. coli</i>.
Lai YH; Franke R; Pinkert L; Overwin H; Brönstrup M.
ACS Infect Dis (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Structural Basis for Cyclosporin Isoform-Specific Inhibition of Cyclophilins from <i>Toxoplasma gondii</i>.
Favretto F; Jiménez-Faraco E; Conter C; Dominici P; Hermoso JA; Astegno A.
ACS Infect Dis (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Single-Chain Polymer Nanoparticles Targeting the Ookinete Stage of Malaria Parasites.
Hamelmann NM; Paats JD; Avalos-Padilla Y; Lantero E; Spanos L; Siden-Kiamos I; Fernàndez-Busquets X; Paulusse JMJ.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Disparate Regions of the Human Chemokine CXCL10 Exhibit Broad-Spectrum Antimicrobial Activity against Biodefense and An…
Crawford MA; Ward AE; Gray V; Bailer P; Fisher DJ; Kubicka E; Cui Z; Luo Q; Gray MC; Criss AK; Lum LG; Tamm LK; Letteri RA; Hughes MA.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Sialosides Containing 7-<i>N</i>-Acetyl Sialic Acid Are Selective Substrates for Neuraminidases from Influenza A Viruse…
Kooner AS; Yuan Y; Yu H; Kang H; Klenow L; Daniels R; Chen X.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Insights into the Spectrum of Activity and Mechanism of Action of MGB-BP-3.
Hind C; Clifford M; Woolley C; Harmer J; McGee LMC; Tyson-Hirst I; Tait HJ; Brooke DP; Dancer SJ; Hunter IS; Suckling CJ; Beveridge R; Parkinson JA; Sutton JM; Scott FJ.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Polymyxin Stereochemistry and Its Role in Antibacterial Activity and Outer Membrane Disruption.
Slingerland CJ; Kotsogianni I; Wesseling CMJ; Martin NI.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
1,3-Diarylpyrazolyl-acylsulfonamides Target HadAB/BC Complex in <i>Mycobacterium tuberculosis</i>.
Singh V; Grzegorzewicz AE; Fienberg S; Müller R; Khonde LP; Sanz O; Alfonso S; Urones B; Drewes G; Bantscheff M; Ghidelli-Disse S; Ioerger TR; Angala B; Liu J; Lee RE; Sacchettini JC; Krieger IV; Jackson M; Chibale K; Ghorpade SR.
ACS Infect Dis (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Synthesis and Structure-Activity Studies of β-Barrel Assembly Machine Complex Inhibitor MRL-494.
Wade N; Wesseling CMJ; Innocenti P; Slingerland CJ; Koningstein GM; Luirink J; Martin NI.
ACS Infect Dis (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade.
Qin R; Kurz E; Chen S; Zeck B; Chiribogas L; Jackson D; Herchen A; Attia T; Carlock M; Rapkiewicz A; Bar-Sagi D; Ritchie B; Ross TM; Mahal LK.
ACS Infect Dis (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared